Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursPaul Cairns, David Sidransky, Thomas J. Polascik et al.|Nature Genetics|1995Cited by 646
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.Theodore D. Kessis, Kathleen R. Cho|Proceedings of the National Academy of Sciences|1993Cited by 530
Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouseRong Wu, Kathleen R. Cho|The Journal of Pathology|2016Cited by 77
Type I to Type II Ovarian Carcinoma ProgressionRong Wu, Kathleen R. Cho|American Journal Of Pathology|2013Cited by 55
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinomaJean C. Tien, Arul M. Chinnaiyan, Gabriel Cruz et al.|Proceedings of the National Academy of Sciences|2025Cited by 6